Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIGAMOX safely and effectively. See full prescribing information for VIGAMOX. VIGAMOX® (moxifloxacin ophthalmic solution), for topical ophthalmic useInitial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
VIGAMOX® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections.
- generic_name
- moxifloxacin hydrochloride
- product_names
- moxifloxacin hydrochloride
- ndc
- 0078-0939, 0078-0939-26
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en